Product Protocols: CXCL9 antibody tested with Human Fetal Liver Tissue (AVARP07022_P050)

Aviva Systems Biology is the original manufacturer of this CXCL9 antibody (AVARP07022_P050)

Click here to view the CXCL9 antibody Western Blot Protocol

Product Datasheet Link: CXCL9 antibody (AVARP07022_P050)

WB Suggested Anti-CXCL9 Antibody Titration: 0.2-1 ug/ml
ELISA Titer: 1:62500
Positive Control: Fetal Liver

Western Blot image:

Description of Target: The function of CXCL9 has not been specifically defined; however, it is thought to be involved in T cell trafficking. This gene has been localized to 4q21 with INP10, which is also a member of the chemokine family of cytokines.The function of this gene has not been specifically defined; however, it is thought to be involved in T cell trafficking. This gene has been localized to 4q21 with INP10, which is also a member of the chemokine family of cytokines. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.

Questions pertaining to this data can be directed to techsupport@avivasysbio.com

Aviva Systems Biology’s CXCL9 antibody (AVARP07022_P050) has been tested using other cell lysates and tissues. To obtain more data about this antibody please email us at info@avivasysbio.com.

To order by phone call us at (888) 880-0001, fax us at (858) 552-6975 or send an email to info@avivasysbio.com. Aviva manufactures this antibody so we can offer the best price. Please contact us to request pricing information.

All of Aviva’s products are guaranteed for the applications and experimental sample types mentioned in the datasheet below. Are you curious if this product will work for you? Please contact us at techsupport@avivasysbio.com

This entry was posted in Western Blot Protocols and tagged , , , , , , . Bookmark the permalink.

Leave a Reply